Current Position: Professor and Chair, Dept. of Otolaryngology - Head & Neck Surgery, University of Tübingen Medical Center

Current Institution:
Eberhard-Karls-Universität Tübingen (EKUT)
Dept of Otolaryngology, Head and Neck Surgery (OHNS)
Elfriede-Aulhorn-Str. 5, 72076 Tübingen, DE

ORCID: 0000-0001-8200-8804

Pubmed

1997: German Board of Otorhinolaryngology, State Chamber of Physicians, Stuttgart, DE
1995: Doctorate, Auditory Physiology, Supervisor: Prof. Klinke, University of Frankfurt, DE
1992-1997: Resident, University of Tübingen Medical School, DE

Since 2016: Professor and Chair Department Otolaryngology- Head & Neck Surgery, Tübingen University Medical center, DE
2014-2016: Professor and Chair, Department Otolaryngology- Head & Neck Surgery, Oldenburg University Medical School, DE
2009-2014: Assoc. Professor and Deputy Chair, Department Otolaryngology- Head & Neck Surgery, Tübingen University Medical center, DE
2006-2014: Consultant in Charge
2006: Habilitation Otorhinolaryngology, University of Tübingen, Prof. Dr. H.P. Zenner
1997-2009: Senior Physician (Oberarzt)
1998: Visiting Research Fellow - Virginia Merrill Boedell Hearing Research Center, University of Washington - Seattle, USA
1997: Visiting Researcher, Dept of Neuroscience and Communication, University of Keele, UK
1993: Visiting Researcher, Dept of Neuroscience, University of Virginia, Charlottesville, USA
1992-1997: Internship/Assistant Doctor, Department Otolaryngology- Head & Neck Surgery, Tübingen University Medical Center, DE

Clinical studies:

• Main investigator: BEMED - Double-blind, placebo-controlled clinical trial “Therapy of Menière's disease with betahistine” (DSGZ, German Dizziness and Balance Center)
  
• Main investigator: Application observation “Vibroplasty Couplers” (Sponsor: Vibrant MedEl, Innsbruck, Austria)
  
• Main investigator: BETAVEST - double-blind, placebo-controlled clinical trial “Effects of betahistine on central vestibular compensation in acute unilateral vestibulopathy” (DSGZ, German Dizziness and Balance Center)
  
• Main investigator: PROVEMIG - double-blind, placebo-controlled clinical trial “Prophylactic treatment of vestibular migraine with metoprolol” (DSGZ, German Dizziness and Balance Center)